As gene-editing treatments move from trials to clinics, experts emphasize the need for rigorous safety monitoring and equitable patient access.
Gene-Editing Therapies Show Promise but Safety Remains Key Challenge
As gene-editing treatments move from trials to clinics, experts emphasize the need for rigorous safety monitoring and equitable patient access.
![[Editorial] Gene-editing therapies: delivering safely for patients](https://nbg1.your-objectstorage.com/ckln/image-assets/0b0c605f714de1e560fe4fa4e784247e8d2891ef64c1e7ae2589ee8c2e8e1ce4.jpg)
CRISPR gene editing · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.